Pilsicainide

Pilsicainide
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral, IV
ATC code	none;
Identifiers
	IUPAC name N-(2,6-dimethylphenyl)-2-(tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetamide;
CAS Number	88069-67-4 ;
PubChem CID	4820;
ChemSpider	4654 ;
UNII	AV0X7V6CSE;
KEGG	D08377 ;
ChEBI	CHEBI:135127;
ChEMBL	ChEMBL163238 ;
CompTox Dashboard (EPA)	DTXSID1046639 ;
Chemical and physical data
Formula	C17H24N2O
Molar mass	272.392 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3;
	InChI InChI=1S/C17H24N2O/c1-13-6-3-7-14(2)16(13)18-15(20)12-17-8-4-10-19(17)11-5-9-17/h3,6-7H,4-5,8-12H2,1-2H3,(H,18,20) ; Key:BCQTVJKBTWGHCX-UHFFFAOYSA-N ;
	(what is this?) (verify)

Pilsicainide (INN) is an antiarrhythmic agent. It is marketed in Japan as サンリズム (Sunrythm). It was developed by Suntory Holdings Limited and first released in 1991.^[1] The JAN applies to the hydrochloride salt, pilsicainide hydrochloride.

^ "Company Timelines". Suntory.

[1] "Company Timelines". Suntory.

[1]

Clinical data

AHFS/Drugs.com	International Drug Names
Routes of administration	Oral, IV
ATC code	none
Identifiers
IUPAC name N-(2,6-dimethylphenyl)-2-(tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetamide
CAS Number	88069-67-4^Y
PubChem CID	4820
ChemSpider	4654^N
UNII	AV0X7V6CSE
KEGG	D08377^Y
ChEBI	CHEBI:135127
ChEMBL	ChEMBL163238^N
CompTox Dashboard (EPA)	DTXSID1046639
Chemical and physical data
Formula	C₁₇H₂₄N₂O
Molar mass	272.392 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3
InChI InChI=1S/C17H24N2O/c1-13-6-3-7-14(2)16(13)18-15(20)12-17-8-4-10-19(17)11-5-9-17/h3,6-7H,4-5,8-12H2,1-2H3,(H,18,20)^N Key:BCQTVJKBTWGHCX-UHFFFAOYSA-N^N
^NY (what is this?) (verify)